Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23961598 | 1.00 | MEN1 (0.40) | MEN1KMT2AMAPTNPC1HTT | |
| SCHEMBL23961555 | 1.00 | MEN1 (0.40) | MEN1KMT2AMAPTNPC1HTT | |
| SCHEMBL21079070 | 0.89 | MEN1 (0.36) | MEN1KMT2AMAPTNPC1HTT | |
| SCHEMBL23961568 | 0.87 | SLC6A3 (0.47) | SLC6A3SLC6A4 | |
| SCHEMBL30138625 | 0.87 | SLC6A3 (0.47) | SLC6A3SLC6A4 | |
| SCHEMBL23933305 | 0.87 | SLC6A3 (0.47) | SLC6A3SLC6A4 | |
| SCHEMBL25870352 | 0.86 | SLC9A1 (0.51) | MEN1KMT2AMAPTHTTLMNA | |
| SCHEMBL20076620 | 0.85 | SLC9A1 (0.40) | MEN1KMT2AMAPTNPC1HTT | |
| SCHEMBL23961569 | 0.83 | MEN1 (0.38) | MEN1KMT2AMAPTLMNATAS1R3 | |
| SCHEMBL23933318 | 0.83 | MEN1 (0.38) | MEN1KMT2AMAPTLMNATAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139272-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | Corteva Agriscience LLC (US) | 2023-03-01 | — | — | EP | claimed |
| CN-115485260-A | Processes related to the formation of aryl cyclopropyl carboxylic acids | 科迪华农业科技有限责任公司 | 2022-12-16 | — | — | CN | claimed |
| WO-2021216629-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | CORTEVA AGRISCIENCE LLC (US) | 2021-10-28 | — | — | WO | claimed |
| US-20230220427-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | CORTEVA AGRISCIENCE LLC (US) | 2023-07-13 | — | — | US | disclosed |
| EP-4139272-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | Corteva Agriscience LLC (US) | 2023-03-01 | — | — | EP | disclosed |
| CN-115485260-A | Processes related to the formation of aryl cyclopropyl carboxylic acids | 科迪华农业科技有限责任公司 | 2022-12-16 | — | — | CN | disclosed |
| WO-2021216629-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | CORTEVA AGRISCIENCE LLC (US) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220427-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | DDT, PCCA, DDC | MEN1 4793/4885KMT2A 3122/4885MAPT 4212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.